Fluconazole
-
Difluzol capsules 150 mg blister 2 pcs Дифлюзол капсулы по 150 мг блистер 2 шт
Dosage form
Capsules №2.
Active ingredient
1 capsule contains fluconazole, in terms of 100 % of the substance, 150 mg.
Indications
Vaginal candidiasis in patients who were previously diagnosed with (or appear sporadically) doctor.
-
Fluconazole-Zdorovye capsules hard 100 mg blister 10 pcs Флуконазол-Здоровье капсулы твердые по 100 мг блистер 10 шт
GENERAL CHARACTERISTICS
Antimycotics for systemic use. Triazole derivatives. ATC Code J02А С01.
Indications to Use:
Treatment of such diseases in adults as:
– cryptococcal meningitis;
– coccidioidomycosis;
– invasive candidiasis;
– candidiasis of the mucous membranes, including candidiasis of the oropharynx and candidiasis of the esophagus candidum, chronic candidiasis of the skin and mucous membranes;
– chronic atrophic candidiasis (candidiasis caused by the use of dentures) with inefficiency of local dental hygiene means;
– vaginal candidiasis, acute or recurrent, when local therapy is inappropriate;
– Balanitis Candida, when local therapy is inappropriate;
– dermatomycosis, including mycosis of feet, mycosis of smooth skin, inguinal dermatomycosis; multicolored lichen and candidal skin infections, when systemic therapy is inappropriate;
– dermatophytic onychomycosis, when the use of other medicines is inappropriate.
Prevention of such diseases in adults as:
– relapse of cryptococcal meningitis in patients with a high risk of its development;
– relapse of candidiasis of the oropharynx or esophagus in HIV-infected patients with a high risk of its development;
– decrease in the frequency of recurrences of vaginal candidiasis (4 or more cases per year);
– prophylaxis of candidiasis infections in patients with prolonged neutropenia (for example, patients with malignant blood diseases who receive chemotherapy or patients in the transplantation of hematopoietic stem cells).
Children. The drug can be used in the form of capsules in this category of patients, when children are able to safely swallow the capsule, usually at the age of 5 years.
The drug is used in children for the treatment of candidiasis of the mucous membranes (candidiasis of the oropharynx, candidosis of the esophagus), invasive candidiasis, cryptococcal meningitis and for the prevention of candidal infections in patients with reduced immunity. The drug can be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in children at high risk of its development.
Therapy can begin before the results of culture and other laboratory studies; after receiving the results, antibiotic therapy should be adjusted accordingly.
-
Fluconazole-Zdorovye capsules 150 mg blister 3 pcs Флуконазол-Здоровье капсулы по 150 мг блистер 3шт
GENERAL CHARACTERISTICS
Antimycotics for systemic use. Triazole derivatives. ATC Code J02А С01.
Indications to Use:
Treatment of such diseases in adults as:
– cryptococcal meningitis;
– coccidioidomycosis;
– invasive candidiasis;
– candidiasis of the mucous membranes, including candidiasis of the oropharynx and candidiasis of the esophagus candidum, chronic candidiasis of the skin and mucous membranes;
– chronic atrophic candidiasis (candidiasis caused by the use of dentures) with inefficiency of local dental hygiene means;
– vaginal candidiasis, acute or recurrent, when local therapy is inappropriate;
– Balanitis Candida, when local therapy is inappropriate;
– dermatomycosis, including mycosis of feet, mycosis of smooth skin, inguinal dermatomycosis; multicolored lichen and candidal skin infections, when systemic therapy is inappropriate;
– dermatophytic onychomycosis, when the use of other medicines is inappropriate.
Prevention of such diseases in adults as:
– relapse of cryptococcal meningitis in patients with a high risk of its development;
– relapse of candidiasis of the oropharynx or esophagus in HIV-infected patients with a high risk of its development;
– decrease in the frequency of recurrences of vaginal candidiasis (4 or more cases per year);
– prophylaxis of candidiasis infections in patients with prolonged neutropenia (for example, patients with malignant blood diseases who receive chemotherapy or patients in the transplantation of hematopoietic stem cells).
Children. The drug can be used in the form of capsules in this category of patients, when children are able to safely swallow the capsule, usually at the age of 5 years.
The drug is used in children for the treatment of candidiasis of the mucous membranes (candidiasis of the oropharynx, candidosis of the esophagus), invasive candidiasis, cryptococcal meningitis and for the prevention of candidal infections in patients with reduced immunity. The drug can be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in children at high risk of its development.
Therapy can begin before the results of culture and other laboratory studies; after receiving the results, antibiotic therapy should be adjusted accordingly.
-
Fluconazole-Zdorovye forte capsules 200 mg blister 4 pcs Флуконазол-Здоровье форте капсулы по 200 мг блистер 4 шт
GENERAL CHARACTERISTICS
Antimycotics for systemic use. Triazole derivatives. ATC Code J02А С01.
Indications to Use:
Treatment of such diseases in adults as:
– cryptococcal meningitis;
– coccidioidomycosis;
– invasive candidiasis;
– candidiasis of the mucous membranes, including candidiasis of the oropharynx and candidiasis of the esophagus candidum, chronic candidiasis of the skin and mucous membranes;
– chronic atrophic candidiasis (candidiasis caused by the use of dentures) with inefficiency of local dental hygiene means;
– vaginal candidiasis, acute or recurrent, when local therapy is inappropriate;
– Balanitis Candida, when local therapy is inappropriate;
– dermatomycosis, including mycosis of feet, mycosis of smooth skin, inguinal dermatomycosis; multicolored lichen and candidal skin infections, when systemic therapy is inappropriate;
– dermatophytic onychomycosis, when the use of other medicines is inappropriate.
Prevention of such diseases in adults as:
– relapse of cryptococcal meningitis in patients with a high risk of its development;
– relapse of candidiasis of the oropharynx or esophagus in HIV-infected patients with a high risk of its development;
– decrease in the frequency of recurrences of vaginal candidiasis (4 or more cases per year);
– prophylaxis of candidiasis infections in patients with prolonged neutropenia (for example, patients with malignant blood diseases who receive chemotherapy or patients in the transplantation of hematopoietic stem cells).
Children. The drug can be used in the form of capsules in this category of patients, when children are able to safely swallow the capsule, usually at the age of 5 years.
The drug is used in children for the treatment of candidiasis of the mucous membranes (candidiasis of the oropharynx, candidosis of the esophagus), invasive candidiasis, cryptococcal meningitis and for the prevention of candidal infections in patients with reduced immunity. The drug can be used as maintenance therapy to prevent the recurrence of cryptococcal meningitis in children at high risk of its development.
Therapy can begin before the results of culture and other laboratory studies; after receiving the results, antibiotic therapy should be adjusted accordingly.
-
Fluconazole-Darnitsa solution for infusion 2 mg/ml bottle 100 ml Флуконазол-Дарница раствор для инфузий 2 мг/мл флакон 100 мл
In adults, for the treatment of: – cryptococcal meningitis; – coccidioidosis; – invasive candidiasis; – mucosal candidiases including candidiasis of the oropharynx and oesophagus, candiduria, chronic candidiasis of the skin and mucosa; – chronic atrophic candidiasis (candidiasis caused by the use of dentures) if local therapy is ineffective. In adults, for the prevention of: – relapse of cryptococcal meningitis in patients with a high risk of its development; – relapse of candidiasis of the oropharynx and oesophagus in patients with HIV with a high risk of its development; – prevention of candidal infections in patients with prolonged neutropenia (e.g. in patients with blood malignancies receiving chemotherapy, or in patients with haematopoietic stem cell transplantation).
-
Fluconazole-Darnitsa capsules 150 mg blister 1 pc Флуконазол-Дарница капсулы по 150 мг блистер 1 шт
Acute vaginal candidiasis, candidal balanitis (when topical therapy is not appropriate).
-
Fluconazole-Darnitsa capsules 100 mg blister 10 pcs Флуконазол-Дарница капсулы по 100 мг блистер 10 шт
Acute vaginal candidiasis, candidal balanitis (when topical therapy is not appropriate).
-
Fluconazole-Darnitsa capsules 50 mg blister 10 pcs Флуконазол-Дарница капсулы по 50 мг блистер 10 шт
Acute vaginal candidiasis, candidal balanitis (when topical therapy is not appropriate).
-
Fluconazole Teva capsules 150 mg No.1 Флуконазол Тева капсулы 150мг №1
Trade name: Fluconazole-Teva
International nonproprietary or generic name:fluconazole
Dosage form: capsules
Composition
1 capsule contains: active ingredient fluconazole 150.00 mg;
excipients: lactose monohydrate 141.00 mg, corn starch 49.95 mg, colloidal anhydrous silicon dioxide 0.3375 mg, sodium lauryl sulfate 0.3375 mg, magnesium stearate 3.375 mg.
